Research Topics
| Marie Claude MoriceSummaryAffiliation: Institut Cardiovasculaire Paris Sud Country: France Publications
| Collaborators
|
Detail Information
Publications
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomesMarie Claude Morice
Institut Cardiovasculaire Paris Sud, Paris, France
EuroIntervention 8:325-35. 2012..SPIRIT Women is the first interventional trial dedicated exclusively to women, focusing on symptoms at presentation, referral time to coronary intervention and the safety and performance of the XIENCE V stent...
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)Marie Claude Morice
Institut Hospitalier Jacques Cartier, Massy, France
EuroIntervention 7:670-9. 2011..The SYNTAX-LE MANS substudy prospectively evaluated 15-month angiographic and clinical outcomes in patients with treated left main (LM) disease...
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and CMarie Claude Morice
Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, Massy, France
Circulation 121:2645-53. 2010....
XIENCE V SPIRIT WOMEN clinical trial: characterization of the female population undergoing stent implantationMarie Claude Morice
Institut Hospitalier Jacques Cartier, ICPS, 6 avenue du Noyer Lambert, 91300 Massy, France
Womens Health (Lond Engl) 4:439-43. 2008..In total, approximately 2000 female patients, derived from the general interventional cardiology population, will be enrolled from up to 130 sites outside of the USA...
Stenting for small coronary vesselsMarie-Claude Morice
L' Institut Cardiovasculaire Paris-Sud, Antony, France
J Invasive Cardiol 15:377-9. 2003
What can we expect from quantitative OCT?Marie Claude Morice
Institut Hospitalier Jacques Cartier, Massy, France
Catheter Cardiovasc Interv 72:236. 2008
[Results of the French register of renal stenting: the Esternal study]M C Morice
Institut Cardiovasculaire Paris Sud, Massy
Arch Mal Coeur Vaiss 100:827-32. 2007..7 +/- 17.1 ml/min vs. 69.2 +/- 160.3. Renal artery stenting in cardiac patients with renal artery stenosis is associated with a very high success rate, with few complications and an improvement in hypertension and renal function...
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trialMarie Claude Morice
Institut Cardiovasculaire Paris Sud, Massy, France
J Am Coll Cardiol 50:1299-304. 2007..This study examined the clinical outcomes at 5 years in RAVEL (A Randomized Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary Revascularization), the first controlled trial of drug-eluting stents...
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trialMarie Claude Morice
Institut Cardiovasculaire Paris Sud, Massy, France
JAMA 295:895-904. 2006....
Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot studyNeus Salvatella
Institut Hospitalier Jacques Cartier, Massy, France
EuroIntervention 7:689-96. 2011....
Transfemoral aortic valve implantation new criteria to predict vascular complicationsKentaro Hayashida
Institut Cardiovasculaire Paris Sud, Massy, France
JACC Cardiovasc Interv 4:851-8. 2011..This study sought to evaluate the incidence, impact, and predictors of vascular complications in transcatheter aortic valve implantation (TAVI)...
Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosisKentaro Hayashida
Institut Cardiovasculaire Paris Sud, Massy, France
J Am Coll Cardiol 59:566-71. 2012..The purpose of this study was to clarify the impact of sex-related differences in transcatheter aortic valve implantation (TAVI) for high-risk patients with severe aortic stenosis...
Reproducibility and factors influencing the assessment of the SYNTAX score in the left main Xience studyPhilippe Garot
Hôpital Claude Galien and Institut Jacques Cartier, Institut Cardiovasculaire Paris Sud, Massy and Quincy, France
Catheter Cardiovasc Interv 80:231-7. 2012..As assessment of SYNTAX score is made by visual estimate of coronary angiography, discrepancies between evaluations by different observers and the impact of observer experience have not yet been evaluated...
True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complicationsKentaro Hayashida
Institut Cardiovasculaire Paris Sud, Massy, France
JACC Cardiovasc Interv 5:207-14. 2012..The purpose of this study was to evaluate the incidence of vascular complications and the predictors of Prostar failure for a "true percutaneous approach" in transfemoral transcatheter aortic valve implantation (TAVI)...
Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: a dual-center registryYves Louvard
Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacquer Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France
Catheter Cardiovasc Interv 55:206-11. 2002....
Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registryBeatriz Vaquerizo
Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
Circulation 119:2349-56. 2009..The objective of this registry was to evaluate the 2-year outcome of elective percutaneous coronary intervention for unprotected LM disease with paclitaxel-eluting stents...
Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registryChristian Spaulding
Cardiology Department, Cochin Hospital, Rene Descartes University, Paris, France
Eur Heart J 27:1054-60. 2006..Because of the limited access to high PTCA volume centres in some areas, it has been suggested that PTCA could be performed in low-volume centres on AMI patients. Little data exist on the validity of this strategy in modern era PTCA...
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2Bernard Chevalier
Institut Cardiovasculaire Paris Sud, Massy Quincy, France
Circ Cardiovasc Interv 2:188-95. 2009..The newly developed Nobori coronary stent coated with a bioresorbable polymer, polylactic acid, and the antiproliferative agent Biolimus A9 has the potential to reduce restenosis by suppressing neointima formation...
Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantationKentaro Hayashida
Institut Cardiovasculaire Paris Sud, Massy, France
JACC Cardiovasc Interv 5:1247-56. 2012..The goal of the study was to clarify the impact of post-procedural aortic regurgitation (post-AR) grade 2/4 on clinical outcomes...
Stenting of bifurcation lesions using the Bestent: a prospective dual-center studyFrancois Gobeil
Institut Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 55:427-33. 2002....
Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantationKentaro Hayashida
Institut Cardiovasculaire Paris Sud, Massy, France
EuroIntervention 8:546-55. 2012..However, computed tomography (CT) has potential advantages compared to TEE. We sought to assess the impact of CT-guided valve sizing on post-procedural aortic regurgitation (AR)...
Late or very late stent thrombosis can also occur with bare metal stentsAndres Rosas Ramos
Institut Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 70:229-32. 2007..In the second case, it occurred three years after the stenting procedure in a bare metal stent implanted in the circumflex artery of a patient who had also received two drug-eluting stents in the left anterior descending coronary artery...
Delayed and recurrent cardiac tamponade following distal coronary perforation of hydrphilic guidewires during coronary interventionFederico De Marco
Cardiologie Interventionelle, Institut Cardiovasculaire Paris Sud ICPS, Massy, France
J Invasive Cardiol 20:E150-3. 2008..In the second case, tamponade was successfully treated with immediate pericardial drainage, but tamponade recurred several days later...
A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarctionChristophe Loubeyre
Institut Cardiovasculaire Paris Sud, Hôpital Claude Galien, Quincy Sous Senart, France
J Am Coll Cardiol 39:15-21. 2002....
Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registryDarren Mylotte
Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, 6 Avenue du Noyer Lamber, Massy, France
EuroIntervention 8:970-81. 2012..Limited long-term data are available to support drug-eluting stent (DES) unprotected left main (LM) intervention. We sought to evaluate long-term outcomes of LM intervention with paclitaxel-eluting stents...
Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarctionPhilippe Garot
Institut Cardiovasculaire Paris Sud, Centre Hospitalier Claude Galien, 20 Route de Boussy, 91480 Quincy, France
Circulation 115:1354-62. 2007..Existing data suggest potential beneficial effects of early myocardial reperfusion, but the predictors of survival in these patients remain unknown...
Use of a deflectable tip catheter to facilitate complex interventions beyond insertion of coronary bypass grafts: three case reportsHelen Routledge
Institute Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 70:862-6. 2007..Use of the Venture Catheter, a deflectable tip 3.5F wire control catheter, facilitated successful percutaneous coronary intervention after prolonged, unsuccessful attempts at conventional guidewire passage...
Duration of balloon inflation for optimal stent deployment: five seconds is not enoughThomas Hovasse
Department of Interventional Cardiology, Institut Hospitalier Jacques Cartier, Massy, France
Catheter Cardiovasc Interv 81:446-53. 2013..To assess the effect of the duration of stent inflation on stent expansion using digital stent enhancement (DSE)...
2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stentsHelen C Routledge
ICPS Institut Cardiovasculaire, Paris Sud, Massy, France
JACC Cardiovasc Interv 1:358-65. 2008....
Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shockPhilippe Garot
Institut Cardiovasculaire Paris Sud, Quincy and Massy, France
EuroIntervention 6:350-5. 2010..Therefore, we hypothesised that statin therapy has an early beneficial effect among patients undergoing PCI for STEMI complicated by cardiogenic shock...
[Percutaneous aortic valve implantation: results and perspectives]Thomas Hovasse
Hôpital privé Jacques Cartier, Institut Cardiovasculaire Paris Sud, 91300 Massy, France
Presse Med 40:732-9. 2011..This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects...
Management of cerebrovascular accidents during cardiac catheterization: immediate cerebral angiography versus early neuroimaging strategyFederico De Marco
Institut Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 70:560-8. 2007..In contrast the use of immediate neuroimaging by means of MRI or CT scan in two cases delayed the implementation of appropriate therapy...
Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularizationDarren Mylotte
Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, and Hopital Claude Galien, Quincy, France
JACC Cardiovasc Interv 6:115-25. 2013....
Percutaneous aortic valve replacement: new hope for inoperable and high-risk patientsHelen C Routledge
Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
J Invasive Cardiol 19:478-83. 2007..The technique, initial results and the current limitations of the procedure are explained alongside the ongoing trials necessary in order that such therapy may eventually be made widely available...
Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trialPhilippe Garot
Institut Cardio vasculaire Paris Sud, Quincy, France
J Am Coll Cardiol 46:606-12. 2005..The aim of this research was to determine the influence of bifurcation lesions on the outcome of patients undergoing percutaneous coronary intervention (PCI) in the recent era...
Acute coronary syndromes: direct stent for all?Christophe Loubeyre
Institut Cardiovasculaire Paris Sud, Quincy, France
J Invasive Cardiol 14:313-4. 2002
Safety and feasibility of the radial approach for primary angioplasty in acute myocardial infarction during pregnancyGyarsi Lal Sharma
Institut Cardiovasculaire Paris Sud, Quincy, France
J Invasive Cardiol 14:359-62. 2002..We present a case of successful primary angioplasty in acute myocardial infarction during pregnancy via the transradial approach without complications. The patient had an uncomplicated recovery with normal left ventricular function...
Noncoronary transradial angioplasty with coronary equipment: a less invasive techniqueG L Sharma
Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacquer Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France
Catheter Cardiovasc Interv 55:197-205. 2002..With the miniaturization of equipment and improvements in technique, this approach will also become an excellent alternative for noncoronary interventions...
Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trialPatrick W Serruys
Thoraxcentre, Rotterdam, The Netherlands
Circulation 106:798-803. 2002..The goal of this intravascular ultrasound investigation was to provide a more detailed morphological analysis of the local biological effects of the implantation of a sirolimus-eluting stent compared with an uncoated stent...
Triple vessel stenting for triple vessel coronary diseaseBeatriz Villegas
Institut Cardiovasculaire Paris Sud, 6 avenue du Noyer Lambert, 91300, Massy, France
J Invasive Cardiol 14:1-5. 2002..Most eligible patients underwent uncomplicated and immediately successful procedures. The long-term outcome was comparable to controlled studies of CABG, except for a higher rate of repeat revascularization procedures due to restenosis...
Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarctionSimon R Dixon
Division of Cardiology, William Beaumont Hospital, 3601 West 13 Mile Road, Royal Oak, MI 48073, USA
Am J Cardiol 91:1454-7, A6. 2003
Successful angioplasty of tripolar renal arteries in a single setting: a case reportGyarsi Lal Sharma
Institut Cardiovasculaire Paris Sud, Massy, France
J Invasive Cardiol 14:457-60. 2002..PTRA combined with stenting is associated with good immediate and long-term results. This case report describes successful angioplasty of bilateral multiple renal arteries in a single setting with good immediate and follow-up results...
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationMarie-Claude Morice
Institut Cardiovasculaire Paris Sud, Massy, France
N Engl J Med 346:1773-80. 2002..CONCLUSIONS: As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events...
Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility studySigmund Silber
Internistische Klinik Dr Müller, Herzkatheterlabor Cardiology Associates, Munich, Germany
J Interv Cardiol 16:491-7. 2003..No other MACE were observed during the three-month follow-up period. Based on the findings of this study, direct stenting with the EXPRESS Stent appears feasible and is well tolerated...
Comparison of 5 French versus 6 French guiding catheters for transradial coronary intervention: a prospective, randomized studyFrancois Gobeil
Notre Dame Hospital, Cardiology Department, Montreal University School of Medicine, 1560 Sherbrooke East Street, H2L 4M1, Montreal, Quebec, Canada
J Invasive Cardiol 16:353-5. 2004..9%; p = 0.05) because of a small radial artery. Transradial intervention using 5 Fr guiding catheters necessitates crossover to a 6 Fr catheter in 6.8% of cases, and offers no clear advantages over the 6 Fr technique...
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phaseAndrew T L Ong
Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
Am Heart J 151:1194-204. 2006..Results of the run-in phase were used by the steering committee to determine eligibility and to project enrollment for each site...
Cause of death with bare metal and sirolimus-eluting stentsDavid R Holmes
Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Eur Heart J 27:2815-22. 2006..There was no significant difference in either the frequency or the cause of death with implantation of either sirolimus-eluting or bare metal stents...
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 356:998-1008. 2007..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
Percutaneous coronary intervention for bifurcation coronary diseaseYves Louvard
Institut Cardiovasculaire Paris Sud, Massy, France
Heart 90:713-22. 2004
The NUGGET study: NIR ultra gold-gilded equivalency trialNicolaus Reifart
Main Taunus Heart Institute, Bad Soden, Germany
Catheter Cardiovasc Interv 62:18-25. 2004..e., higher neointimal hyperplasia in spite of a significantly better initial gain), with higher restenosis and similar MACE rates at 6 months...
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trialJean Fajadet
Clinique Pasteur, 45, Avenue du Lombez, 31300 Toulouse, France
Circulation 111:1040-4. 2005..This analysis examined whether these beneficial effects persist over the longer term...
Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysisMuzaffer Degertekin
Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
Circulation 108:2747-50. 2003..CONCLUSIONS: Vessel dimensions and area of ISA did not change over time, except for 1 coronary aneurysm that became apparent. ISA after implantation of a SES was not associated with adverse events at late follow-up...
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL TrialAlexandre Abizaid
Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
Eur Heart J 25:107-12. 2004..007). Conclusion Diabetics treated with SES were associated with a virtual abolition of neointimal proliferation and low event rates at long-term follow-up...
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stentsEugenia Nikolsky
Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
Catheter Cardiovasc Interv 71:896-906. 2008..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
Gender-specific outcomes after sirolimus-eluting stent implantationEmilia Solinas
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 50:2111-6. 2007..We examined the impact of gender on outcomes of patients undergoing percutaneous coronary intervention using sirolimus-eluting stents (SES)...
Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)Remo Albiero
Columbus Hospital, Milan, Italy
J Am Coll Cardiol 43:943-9. 2004..e., percutaneous transluminal coronary angioplasty [PTCA]) for the treatment of patients with coronary in-stent restenosis (ISR)...
Collateral coronary circulation in the absence of obstructive coronary artery diseaseRajpal Abhaichand
Institut Cardiovasculaire Paris Sud, Massy, France
J Invasive Cardiol 14:331-3. 2002..We believe that this vessel is of congenital origin and after reviewing the literature we describe the angiographic features that distinguish such a vessel from collaterals that are secondary to coronary stenosis or hypoxia...
Stent supported angioplasty for coronary arterial stenosis following the arterial switch operationRajpal Abhaichand
Institut Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 56:278-80. 2002..We could not find a similar report in the literature...
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialStephan Windecker
Department of Cardiology, and CTU Bern, Bern University Hospital, Bern, Switzerland
Lancet 372:1163-73. 2008..We compared the safety and efficacy of a biolimus-eluting stent (with biodegradable polymer) with a sirolimus-eluting stent (with durable polymer)...
Less invasive PTCA of a gastroepiploic artery combining the transradial approach and 5 Fr guiding catheter: a case reportGyarsi Lal Sharma
Institut Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 56:494-7. 2002..In the case presented here, a gastroepiploic graft stenosis was treated by balloon angioplasty performed through a less invasive approach combining transradial access and use of 5 Fr guiding catheter...
